Abbott’s Drug Eluting Stents Receive Europe Nod for Treating Diabetics

by Gopalan on  November 06, 2009 at 1:49 PM General Health News
  •   Print
  •   Share
  •   Comments
  •  Text 
Abbott’s drug eluting stents, XIENCE PRIME™ Everolimus Eluting Coronary Stent System and the XIENCE V® Everolimus Eluting Coronary Stent System have both received additional new CE Markings (Conformité Européenne), covering the treatment of patients with diabetes.

The CE marking certifies that a product has met EU consumer safety, health or environmental requirements.

Coronary artery disease is one of the most common cardiovascular complications of diabetes and is the number one cause of death among European adults with diabetes.

The high blood glucose levels associated with diabetes can lead to increased deposits of fatty materials on the insides of the blood vessel walls. These deposits may affect blood flow to the heart, increasing the chance of clogging and hardening of blood vessels.

Patients with diabetes who also have coronary artery disease often have poorer outcomes after stent procedures because their blood vessels tend to build up more plaque than the vessels of non-diabetic patients, and their coronary artery disease advances more quickly.

"This expanded indication further confirms XIENCE PRIME and XIENCE V as important options for physicians who are treating patients with diabetes," said Charles Simonton, M.D., FACC, FSCAI, divisional vice president, Medical Affairs, and chief medical officer, Abbott Vascular. "Patients with diabetes tend to be sicker and have more challenging anatomy, such as small vessels or long lesions, which can be difficult to treat.

The deliverability of both devices provides physicians with confidence to easily reach the lesion site."

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

General News

» Reduction In Cost Of Anti Malarial Drugs Thanks To New Process » Younger People Who are Disagreeable Likelier to Prefer Aggressive Dogs
» Texas Photographer Creates Calendar With Pictures of Dogs in Yoga Positions » Polio Eradication at “Tipping Point,” Says WHO Chief
» Web-Based Decision Support System to Help People Select Right Wheelchairs » Study Says People Unaware About Dangers of Bee Pollen Supplements
» Sex Change Surgeries to be Included in Chilean Public Health Plan » WHO to Approve New Target for Cutting Down Chronic Illness Deaths
Read More >>